Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2021 Filed Jun 28, 2021 20:03 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,370 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001437749-21-015796 · rdgdoc.xml · derivative · entry 5 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,370 shares Expires 2023-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sales and stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:03 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | Not disclosed | $0.00 Strike: $21.68 | $6,391.00 |
DisclosureSEC source: 0001437749-21-015796 · rdgdoc.xml · derivative · entry 4 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,391 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sales and stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:03 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 6,761 | $55.00 | $371,855.00 |
DisclosureSEC source: 0001437749-21-015796 · rdgdoc.xml · nonDerivative · entry 3 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,533 F1 · kind: Sales and stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:03 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionCommon Stock | 1,370 | $10.00 | $13,700.00 |
DisclosureSEC source: 0001437749-21-015796 · rdgdoc.xml · nonDerivative · entry 2 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sales and stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:03 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionCommon Stock | 6,391 | $21.68 | $138,556.88 |
DisclosureSEC source: 0001437749-21-015796 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sales and stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:09 UTC |
ROCHE KEVIN HDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012786 · rdgdoc.xml · nonDerivative · entry 1 ROCHE KEVIN H · CIK 0001024356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:12 UTC |
SODERBERG PETER HDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012789 · rdgdoc.xml · nonDerivative · entry 1 SODERBERG PETER H · CIK 0001192977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,844 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:11 UTC |
BURKE WILLIAM WDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012788 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,533 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:10 UTC |
NIGON RICHARDDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012787 · rdgdoc.xml · nonDerivative · entry 1 NIGON RICHARD · CIK 0001213869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,131 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:08 UTC |
Dodd Sheri LouiseDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012785 · rdgdoc.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:04 UTC |
Huggenberger RaymondDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012779 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,933 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:06 UTC |
Jain DeeptiDirector
|
GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012781 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 13, 2021 Filed May 17, 2021 12:56 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 800 | $52.08 | $41,664.00 |
DisclosureSEC source: 0001437749-21-012407 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,043 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
PAULS ERICSenior VP, Sales
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,153 | $0.00 Strike: $54.10 | $0.00 |
DisclosureSEC source: 0001437749-21-011366 · rdgdoc.xml · derivative · entry 3 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153 Underlying: Common Stock · 3,153 shares Expires 2028-05-05 F2 · derivative.exercise_date: One-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
PAULS ERICSenior VP, Sales
|
GrantCommon Stock | 4,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-011366 · rdgdoc.xml · nonDerivative · entry 2 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,955 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
PAULS ERICSenior VP, Sales
|
GrantCommon Stock | 1,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-011366 · rdgdoc.xml · nonDerivative · entry 1 PAULS ERIC · CIK 0001857667 · Senior VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,334 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,094 | $0.00 Strike: $54.10 | $0.00 |
DisclosureSEC source: 0001437749-21-011365 · rdgdoc.xml · derivative · entry 3 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,094 Underlying: Common Stock · 5,094 shares Expires 2028-05-05 F2 · derivative.exercise_date: One-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 4,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-011365 · rdgdoc.xml · nonDerivative · entry 2 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,777 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 21:10 UTC |
Burns KristieSr. VP Mktg & Clinical Affairs
|
GrantCommon Stock | 2,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-011365 · rdgdoc.xml · nonDerivative · entry 1 Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:35 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 174 | $47.33 | $8,234.90 |
DisclosureSEC source: 0001437749-21-005438 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,691 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:34 UTC |
Rishe BryanSVP, Sales
|
SaleCommon Stock | 196 | $47.15 | $9,241.79 |
DisclosureSEC source: 0001437749-21-005437 · rdgdoc.xml · nonDerivative · entry 1 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,567 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:18 UTC |
Moen BrentChief Financial Officer
|
SaleCommon Stock | 1,429 | $50.91 | $72,747.25 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 3 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,865 F3 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:17 UTC |
Rishe BryanSVP, Sales
|
SaleCommon Stock | 1,062 | $50.90 | $54,055.91 |
DisclosureSEC source: 0001437749-21-004702 · rdgdoc.xml · nonDerivative · entry 3 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,763 F3 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:18 UTC |
Moen BrentChief Financial Officer
|
Tax withholdingCommon Stock | 826 | $54.12 | $44,703.12 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,294 F2 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of performance stock units. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:17 UTC |
Rishe BryanSVP, Sales
|
Tax withholdingCommon Stock | 2,341 | $54.12 | $126,694.92 |
DisclosureSEC source: 0001437749-21-004702 · rdgdoc.xml · nonDerivative · entry 2 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,825 F2 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of performance stock units. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 01:37 UTC |
Dodd Sheri LouiseDirector
|
GrantCommon Stock | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004641 · rdgdoc.xml · nonDerivative · entry 1 Dodd Sheri Louise · CIK 0001837111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2021. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 01:36 UTC |
Jain DeeptiDirector
|
GrantCommon Stock | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004640 · rdgdoc.xml · nonDerivative · entry 1 Jain Deepti · CIK 0001840203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2021. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:19 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,456 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001437749-21-004705 · rdgdoc.xml · derivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,456 Underlying: Common Stock · 19,456 shares Expires 2028-02-25 F2 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:19 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 7,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004705 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,691 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:18 UTC |
Moen BrentChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,835 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · derivative · entry 4 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,835 Underlying: Common Stock · 13,835 shares Expires 2028-02-25 F4 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:18 UTC |
Moen BrentChief Financial Officer
|
GrantCommon Stock | 5,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004703 · rdgdoc.xml · nonDerivative · entry 1 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,120 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:17 UTC |
Rishe BryanSVP, Sales
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,053 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001437749-21-004702 · rdgdoc.xml · derivative · entry 4 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,053 Underlying: Common Stock · 6,053 shares Expires 2028-02-25 F4 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:17 UTC |
Rishe BryanSVP, Sales
|
GrantCommon Stock | 2,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004702 · rdgdoc.xml · nonDerivative · entry 1 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,166 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:42 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001437749-21-000298 · rdgdoc.xml · derivative · entry 3 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370 Underlying: Common Stock · 1,500 shares Expires 2023-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:42 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 1,500 | $45.13 | $67,695.00 |
DisclosureSEC source: 0001437749-21-000298 · rdgdoc.xml · nonDerivative · entry 2 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,843 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:42 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionCommon Stock | 1,500 | $10.00 | $15,000.00 |
DisclosureSEC source: 0001437749-21-000298 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:47 UTC |
SODERBERG PETER HDirector
|
GrantCommon Stock | 250 | $44.94 | $11,235.00 |
DisclosureSEC source: 0001437749-21-000147 · rdgdoc.xml · nonDerivative · entry 1 SODERBERG PETER H · CIK 0001192977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,354 F1 · shares: On December 31, 2020, the reporting person was granted 250 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. F1 · price: On December 31, 2020, the reporting person was granted 250 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:40 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001437749-20-022545 · rdgdoc.xml · derivative · entry 3 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,870 Underlying: Common Stock · 1,500 shares Expires 2023-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:40 UTC |
BURKE WILLIAM WDirector
|
SaleCommon Stock | 1,500 | $37.50 | $56,250.00 |
DisclosureSEC source: 0001437749-20-022545 · rdgdoc.xml · nonDerivative · entry 2 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,843 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:40 UTC |
BURKE WILLIAM WDirector
|
Exercise / conversionCommon Stock | 1,500 | $10.00 | $15,000.00 |
DisclosureSEC source: 0001437749-20-022545 · rdgdoc.xml · nonDerivative · entry 1 BURKE WILLIAM W · CIK 0001200612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2020. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:27 UTC |
SODERBERG PETER HDirector
|
GrantCommon Stock | 307 | $36.59 | $11,233.13 |
DisclosureSEC source: 0001437749-20-020679 · rdgdoc.xml · nonDerivative · entry 1 SODERBERG PETER H · CIK 0001192977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,104 F1 · shares: On September 30, 2020, the reporting person was granted 307 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. F1 · price: On September 30, 2020, the reporting person was granted 307 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. Read SEC document |
| September 02, 2020 Filed Sep 11, 2020 20:25 UTC |
Moen BrentChief Financial Officer
|
Tax withholdingCommon Stock | 486 | $36.94 | $17,952.84 |
DisclosureSEC source: 0001437749-20-019636 · rdgdoc.xml · nonDerivative · entry 2 Moen Brent · CIK 0001512710 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,953 F1 · shares: Consists of shares withheld by the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock units. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,818 | $0.00 Strike: $36.50 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · derivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,818 Underlying: Common Stock · 24,818 shares Expires 2027-08-05 F4 · derivative.exercise_date: Stock option vests fully on June 30, 2021, subject to the requirement that the Company's stock price exceeds $40.15 for 20 consecutive trading days during the term of the stock option. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,210 | $0.00 Strike: $36.50 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · derivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,210 Underlying: Common Stock · 26,210 shares Expires 2027-08-05 F3 · derivative.exercise_date: One-third of the stock option vests on each of the first three anniversaries of the grant date, subject to the requirement that the Company's stock price exceeds $40.15 for 20 consecutive trading days during the term of the stock option. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 9,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,424 F2 · shares: RSUs that vest fully on June 30, 2021. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC |
REUVERS DANIEL L.Director · President and CEO
|
GrantCommon Stock | 10,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,178 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:38 UTC |
SODERBERG PETER HDirector
|
GrantCommon Stock | 271 | $41.43 | $11,227.53 |
DisclosureSEC source: 0001437749-20-014542 · rdgdoc.xml · nonDerivative · entry 1 SODERBERG PETER H · CIK 0001192977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 F1 · shares: On June 30, 2020, the reporting person was granted 271 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. F1 · price: On June 30, 2020, the reporting person was granted 271 restricted stock units ("RSUs") in lieu of cash compensation of $11,250.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Mr. Soderberg's separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:53 UTC |
Rishe BryanSVP, Sales
|
SaleCommon Stock | 2,331 | $40.66 | $94,778.46 |
DisclosureSEC source: 0001437749-20-014143 · rdgdoc.xml · nonDerivative · entry 1 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,906 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 22:35 UTC |
Rishe BryanSVP, Sales
|
SaleCommon Stock | 2,330 | $44.77 | $104,314.10 |
DisclosureSEC source: 0001437749-20-013064 · rdgdoc.xml · nonDerivative · entry 1 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,237 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| May 26, 2020 Filed May 28, 2020 21:27 UTC |
Rishe BryanSVP, Sales
|
SaleCommon Stock | 2,330 | $50.10 | $116,733.00 |
DisclosureSEC source: 0001437749-20-011952 · rdgdoc.xml · nonDerivative · entry 1 Rishe Bryan · CIK 0001649328 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,567 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · balance_after: Includes 449 shares acquired on May 15, 2020 pursuant to the issuer's employee stock purchase plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.